Date published: 2025-10-28

1-800-457-3801

SCBT Portrait Logo
Seach Input

ACSL6 Activators

ACSL6 Activators are a specific group of chemical compounds that facilitate the enhancement of the functional activity of Acyl-CoA synthetase long-chain family member 6 (ACSL6). ACSL6 is an enzyme that plays a pivotal role in the metabolism of long-chain fatty acids by catalyzing the conversion of these fatty acids into their corresponding acyl-CoA derivatives, which are then primed for subsequent metabolic pathways such as beta-oxidation, lipid synthesis, and signaling lipid production. The chemical compounds that act as ACSL6 Activators achieve this enhancement through various mechanisms, including allosteric modulation, substrate availability alteration, and transcriptional regulation, all of which are integral to maintaining cellular lipid homeostasis.

These activators include compounds that engage with proteins or receptors that directly or indirectly upregulate ACSL6 activity. Compounds like SRT1720, Leptin, and AICAR operate through the activation of proteins such as SIRT1 and AMPK, which promote the post-translational modification of ACSL6, leading to its enhanced activity. These modifications can alter the enzyme's conformation, stability, or interaction with other cellular components, consequently increasing its functionality. Furthermore, the activation of nuclear receptors such as PPARα by specific agonists like GW7647, Bezafibrate, and WY-14643 results in the upregulation of ACSL6 gene expression, leading to an increase in enzyme levels and activity within the cell.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SRT1720

1001645-58-4sc-364624
sc-364624A
5 mg
10 mg
$193.00
$357.00
13
(1)

SRT1720 is a specific activator of SIRT1, which can enhance fatty acid oxidation by deacetylating ACSL6, leading to its activation. SIRT1-mediated deacetylation is known to activate several metabolic enzymes.

Ob (hBA-147)

sc-4912
1000 µg
$253.00
1
(0)

Leptin can enhance fatty acid oxidation through activation of AMPK, which in turn can increase ACSL6 activity, linking hormonal signaling with lipid metabolism.

AICAR

2627-69-2sc-200659
sc-200659A
sc-200659B
50 mg
250 mg
1 g
$60.00
$270.00
$350.00
48
(2)

AICAR activates AMPK, which can then phosphorylate and enhance the activity of ACSL6, thus promoting the utilization of fatty acids.

Bezafibrate

41859-67-0sc-204650B
sc-204650
sc-204650A
sc-204650C
500 mg
1 g
5 g
10 g
$30.00
$45.00
$120.00
$200.00
5
(1)

Bezafibrate is a PPAR pan-agonist that can increase the transcription of ACSL6, among other genes, leading to enhanced fatty acid metabolism.

GW 7647

265129-71-3sc-203068A
sc-203068
sc-203068B
sc-203068C
1 mg
5 mg
10 mg
25 mg
$48.00
$167.00
$262.00
$648.00
6
(1)

GW7647 is a potent PPARα agonist that can upregulate the expression of ACSL6, promoting its activity in lipid metabolism pathways.

Fenofibrate

49562-28-9sc-204751
5 g
$40.00
9
(1)

Fenofibrate, through its action as a PPARα agonist, can enhance the expression and activity of ACSL6, thereby increasing fatty acid oxidation.

WY 14643

50892-23-4sc-203314
50 mg
$133.00
7
(1)

WY-14643 is a PPARα agonist known to upregulate genes involved in fatty acid metabolism, including ACSL6, thus enhancing its enzymatic activity.

Pioglitazone

111025-46-8sc-202289
sc-202289A
1 mg
5 mg
$54.00
$123.00
13
(1)

Although primarily a PPARγ agonist, Pioglitazone can also influence PPARα-related pathways, possibly leading to increased ACSL6 activity.

Rosiglitazone

122320-73-4sc-202795
sc-202795A
sc-202795C
sc-202795D
sc-202795B
25 mg
100 mg
500 mg
1 g
5 g
$118.00
$320.00
$622.00
$928.00
$1234.00
38
(1)

Rosiglitazone is a PPARγ agonist that may have secondary effects on ACSL6 function and expression due to cross-talk between PPARγ and PPARα signaling.

Palmitoylethanolamide

544-31-0sc-202754
sc-202754A
sc-202754B
sc-202754C
sc-202754D
10 mg
50 mg
500 mg
1 g
10 g
$78.00
$238.00
$2050.00
$3274.00
$16330.00
(1)

Palmitoylethanolamide may enhance ACSL6 activity by increasing substrate availability through its actions as an endogenous fatty acid ethanolamide.